Promising cell therapy offers hope for relapsed or refractory T-cell leukaemia

A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment options. Published in the medical journal Nature Medicine on 3 September 2024, the study…